financetom
Business
financetom
/
Business
/
ICU Medical Q2 Adjusted Earnings Rise, Revenue Falls; Full-Year EPS Guidance Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ICU Medical Q2 Adjusted Earnings Rise, Revenue Falls; Full-Year EPS Guidance Revised
Aug 8, 2025 1:43 AM

04:15 AM EDT, 08/08/2025 (MT Newswires) -- ICU Medical ( ICUI ) reported Q2 adjusted earnings late Thursday of $2.10 per diluted share, up from $1.56 a year earlier.

Analysts polled by FactSet expected $1.50.

Adjusted revenue for the quarter ended June 30 was $543.6 million, compared with $581 million a year earlier.

Analysts surveyed by FactSet expected $540.1 million.

The company said it now expects full-year adjusted EPS of $6.85 to $7.15, compared with its prior outlook range of $6.55 to $7.25. Analysts are looking for $6.75.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Odyssey Marine Exploration Insider Sold Shares Worth $944,928, According to a Recent SEC Filing
Odyssey Marine Exploration Insider Sold Shares Worth $944,928, According to a Recent SEC Filing
Oct 15, 2025
05:08 PM EDT, 10/15/2025 (MT Newswires) -- John D Longley Jr, President & COO, on October 13, 2025, sold 256,049 shares in Odyssey Marine Exploration ( OMEX ) for $944,928. Following the Form 4 filing with the SEC, Longley has control over a total of 150,313 common shares of the company, with 150,313 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/798528/000119312525240389/xslF345X05/ownership.xml ...
Cryo-Cell International Q3 revenue, net income fall
Cryo-Cell International Q3 revenue, net income fall
Oct 15, 2025
Overview * Cryo-Cell ( CCEL ) fiscal Q3 revenue decreased 3% yr/yr to $7.83 mln * The cord blood bank firm's net income for fiscal Q3 fell to $749,000 from $1.05 mln yr/yr Outlook * Company did not provide specific guidance for future quarters or the full year in the press release Key Details Metric Beat/Mis Actual Consensu s s...
D-Wave Quantum Insider Sold Shares Worth $349,685, According to a Recent SEC Filing
D-Wave Quantum Insider Sold Shares Worth $349,685, According to a Recent SEC Filing
Oct 15, 2025
05:07 PM EDT, 10/15/2025 (MT Newswires) -- John M. Markovich, Chief Financial Officer, on October 14, 2025, sold 7,994 shares in D-Wave Quantum ( QBTS ) for $349,685. Following the Form 4 filing with the SEC, Markovich has control over a total of 1,580,934 common shares of the company, with 1,580,934 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1907982/000190798225000228/xslF345X05/wk-form4_1760562236.xml ...
Beta Technologies aims for $7.22 billion valuation in US IPO
Beta Technologies aims for $7.22 billion valuation in US IPO
Oct 15, 2025
(Reuters) -Electric aircraft maker Beta Technologies said in a regulatory filing on Wednesday that it was aiming for a U.S. listing valuing the company at about $7.22 billion. Vermont-based Beta plans to offer 25 million shares priced between $27 and $33 each and is seeking to raise up to $825 million. The offering comes amid a rebound in U.S. IPO...
Copyright 2023-2026 - www.financetom.com All Rights Reserved